Corient Private Wealth
IBB icon

Corient Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Corient Private Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
56,763
-631
-1% -$108K 0.01% 617
2026
Q1 		$9.39M Sell
57,394
-4,833
-8% -$826K 0.01% 646
2025
Q4 		$10.5M Buy
62,227
+33,099
+114% +$5.38M 0.01% 547
2025
Q3 		$4.21M Sell
29,128
-27,402
-48% -$3.74M 0.01% 768
2025
Q2 		$7.15M Sell
56,530
-63,814
-53% -$7.83M 0.01% 602
2025
Q1 		$15.4M Buy
120,344
+45,010
+60% +$6.1M 0.03% 432
2024
Q4 		$9.72M Sell
75,334
-9,680
-11% -$1.36M 0.02% 521
2024
Q3 		$12.4M Sell
85,014
-4,003
-4% -$579K 0.02% 514
2024
Q2 		$12.2M Sell
89,017
-554
-0.6% -$74K 0.02% 482
2024
Q1 		$12.3M Buy
89,571
+2,871
+3% +$392K 0.02% 479
2023
Q4 		$11.8M Buy
86,700
+841
+1% +$103K 0.02% 482
2023
Q3 		$10.5M Sell
85,859
-4,277
-5% -$544K 0.02% 466
2023
Q2 		$11.4M Sell
90,136
-6,447
-7% -$837K 0.03% 453
2023
Q1 		$12.5M Buy
96,583
+35,405
+58% +$4.63M 0.03% 401
2022
Q4 		$8.03M Buy
+61,178
New +$7.91M 0.03% 407

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Corient Private Wealth's IBB Position: Q2 2026 in Review

Corient Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 1.1% in Q2 2026, selling an estimated $108K and leaving 56,763 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #617.

Corient Private Wealth first reported a position in IBB in Q4 2022 and has held it in 15 quarters since. The position peaked at $15.4M in Q1 2025. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Corient Private Wealth held 56,763 shares of iShares Biotechnology ETF worth $10.8M as of Q2 2026.
  • Corient Private Wealth sold 631 iShares Biotechnology ETF shares in Q2 2026, an estimated $108K.
  • iShares Biotechnology ETF made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #617 holding.
  • Corient Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's iShares Biotechnology ETF position peaked at $15.4M in Q1 2025.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.